The malignant brain tumor type medulloblastoma can become resistant to therapy which can cause relapse. Researchers have discovered a...

Children who received radiotherapy which exposed their head are at increased risk of developing a type of brain tumour called a...

A new antibody therapy for children with medulloblastoma has shown promise during a Phase I clinical trial. The antibody, which targets a...

Tested using a new brain tissue model, the particles may be able to deliver chemotherapy drugs for glioblastoma. Read more:...

Scientists have found a novel cause of aggressive pediatric brain cancer. The St. Jude Children's Research Hospital study is the first to...

A researcher has found, through extensive data analysis, that the youngest patients with brain tumors -- those ages birth to 3 months...

Researchers hope to replicate the successes in pediatric acute lymphoblastic leukemia — among the most common pediatric cancers — by ...

Metformin, a drug commonly prescribed against diabetes, holds promise against a rare type of childhood brain tumor in laboratory...

An innovative clinical trial led by Dr. Nicholas Vitanza, a neuro-oncologist at Seattle Children’s, shows promise that delivering ...

Two experimental drug approaches that target vulnerabilities in cancer cell metabolism may extend survival and enhance the effectiveness...